KLRK1 and Miyoshi myopathy: Among NK cell activating receptors involved in recognition and killing of malignant PCs, a prominent role is played by the activating receptors natural-killer group 2, member D (NKG2D) and DNAX accessory molecule-1 (DNAM-1) engaged by their ligands on MM cells [51].